Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis

Multiple sclerosis is an inflammatory neurodegenerative disease of the central nervous system (CNS) and the most frequent cause of non-traumatic disability in adults in the Western world. Currently, several drugs have been approved for the treatment of multiple sclerosis. While the newer drugs are m...

Descripción completa

Detalles Bibliográficos
Autores principales: Aram, Jehan, Francis, Anna, Tanasescu, Radu, Constantinescu, Cris S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534644/
https://www.ncbi.nlm.nih.gov/pubmed/30506485
http://dx.doi.org/10.1007/s40120-018-0120-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534644/
https://www.ncbi.nlm.nih.gov/pubmed/30506485
http://dx.doi.org/10.1007/s40120-018-0120-1

Ejemplares similares